The Seroprevalence of Canine Leishmaniasis and a Retrospective Survey of Human Leishmaniasis in the Constantine Region of Algeria
-
Nazim Messaoudi
,
Samir Djemai
,
Fayçal Zeroual
,
Noureddine Zeghilet
,
Abdelfateh Beghriche
,
Latifa Boultif
,
Adam B Borhan Eddine Bessou
Abstract
Background: In Algeria, leishmaniasis is characterized by an endemic nature, which appears in humans in the two known forms: visceral leishmaniasis (VL) and cutaneous leishmaniasis (CL). This study aimed to determine the seroprevalence of canine leishmaniasis within a group of dogs and the incidence of human leishmaniasis.
Methods: We performed a serological survey of canine leishmaniasis (CanL) in 84 asymptomatic dogs in Constantine wilaya (north-west of Algeria). The collected dog sera were tested by the indirect ELISA method. The study considered multiple risk factors, including the breed, sex, age, and location of the dogs. The dogs whose blood samples were taken during this survey came from the following municipalities in Constantine: El-Khroub, Ali Mendjeli, Zighoud Youcef, Aïn Smara, Hamma Bouziane, Didouche Mourad, and Constantine. In parallel, an epidemiological study of human leishmaniasis in the Constantine region was conducted. We collected retrospective data on the two forms of human leishmaniasis from Constantine's Department of Public Health between 2016 and 2024.
Results: The incidence of CanL observed in the study was 8.33% (with 7 dogs testing positive. During the nine-year study period, 136 cases of CL and VL were recorded. The predominance of CL (with 124 cases, 91.18%) over VL (12 cases, 8.82%) was statistically significant (χ²=92.24; P<0.001) throughout the study duration.
Conclusion: The high seroprevalence of leishmaniasis in asymptomatic owned dogs, along with the significant frequency of human cases of CL and VL in the Constantine region, indicated that leishmaniasis remained a major public health problem in Algeria.
2. Baneth G, Petersen C, Solano-Gallego L, et al. Leishmaniosis. In: Sykes JE, editor. Greene's Infectious Diseases of the Dog and Cat. 5th ed. Amsterdam: Elsevier Health Science; 2021. p. 1179-1202.
3. Morales-Yuste M, Martín-Sánchez J, Corpas-Lopez V. Canine leishmaniasis: Update on epidemiology, diagnosis, treatment, and prevention. Vet Sci. 2022;9(8):387.
4. Kerkoub H, Saidani K, Righi S, et al. Epidemiology and Clinical Management of Canine Leishmaniasis in northeastern Algeria: A Preliminary Study. Comp Immunol Microbiol Infect Dis. 2025;116:102275.
5. Solano-Gallego L, Miró G, Koutinas A, Cardoso L, et al. LeishVet guidelines for the practical management of canine leishmaniosis. Parasit Vectors. 2011; 4:86.
6. Khelifi-Touhami NA, Ouchene N, Ouchetati I, Naghib I. Animal leishmaniasis in Algeria: A systematic review and meta-analysis. Comp Immunol Microbiol Infect Dis. 2023;93:101930.
7. Adel A, Abatih E, Speybroeck N, et al. Estimation of canine Leishmania infection prevalence in six cities of the Algerian littoral zone using a Bayesian approach. PLoS One. 2015; 10(3):e0117313.
8. Bellatreche AY, Medkour H, Blaga R, et al. Evaluation of commercial ELISA, indirect immunofluorescence test and qPCR for the diagnosis of Leishmania infantum in asymptomatic dogs from Bouira, northeast Algeria. Veterinaria. 2021;70(1):15-25.
9. Boussetti S, Yahia A. Integration of GIS and multi-criteria hierarchical analysis for urban planning support: case of the wilaya of Constantine. Int J Innov Technol Soc Sci. 2024;4(44):3032.
10. Sahnoune NS, Imane NK, Marwa NM. Analysis of climate change effect on extreme precipitation event in Constantine, Algeria. Int J Innov Technol Soc Sci. 2024;2(42):8128.
11. El-Mouhdi K, Boussaa S, Chahlaoui A, et al. Prevalence and risk factors of canine leishmaniasis in Morocco: a systematic review and meta-analysis. J Parasit Dis. 2022;46(4):967-87.
12. Messaoudene F, Boukraa S, Boubidi SC, et al. Human cutaneous leishmaniasis in North Africa and its threats to public health: a statistical study focused on Djelfa (Algeria). Microorganisms. 2023;11(10):2608.
13. Adel A, Boughoufalah A, Saegerman C, et al. Epidemiology of visceral leishmaniasis in Algeria: an update. PLoS One. 2014; 9(6):e99207.
14. Fendri AH, Beldjoudi W, Ahraou S, et al. Les leishmanioses diagnostiquées au CHU Benbadis de Constantine (Algérie): bilan de cinq années (2006-2010). Bull Soc Pathol Exot. 2012; 105(1):46-8.
15. Siala E, Bouratbine A, Aoun K. Mediterranean visceral leishmaniasis: update on biological diagnosis. Tunis Med. 2022;100(1):13-26.
16. Mohamed-Cherif AM, Bellatreche AY, Ait-Oudhia K. A cross-sectional study of Leishmania infantum infection in stray cats in Algiers' suburbs, Algeria, and evaluation of serological and molecular tests for its diagnosis. Veterinaria. 2022;71(1):73.
17. Ciaramella P, Oliva G, De Luna R, et al. A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum. Vet Rec. 1997;141(21):539-43.
18. Izri A, Bendjaballah-Laliam A, Sereno D, et al. Updates on geographical dispersion of Leishmania parasites causing cutaneous affections in Algeria. Pathogens. 2021;10(3):267.
19. Jansen A, Stark K, Schneider T, Schoneberg I. Sex differences in clinical leptospirosis in Germany: 1997-2005. Clin Infect Dis. 2007;44(9): e69-72.
20. Schlagenhauf P, Chen LH, Wilson ME, et al. Sex and gender differences in travel-associated disease. Clin Infect Dis. 2010;50(6):826-32.
21. Dahal P, Singh-Phulgenda S, Maguire BJ, et al. Visceral leishmaniasis in pregnancy and vertical transmission: a systematic literature review on the therapeutic orphans. PLoS Negl Trop Dis. 2021; 15(8):e0009650.
22. Mohebali M, Edrissian GhH, Akhoundi B, et al. Visceral leishmaniasis in Iran: an update on epidemiological features from 2013 to 2022. Iran J Parasitol. 2023;18(3):279-93.
23. Eddaikra N, Benikhlef R, Sereno D. A century of epidemiological advances in cutaneous and visceral leishmaniasis in Algeria. J Parasitol Res. 2025;2025:2102270.
24. Cloots K, Burza S, Malaviya P, et al. Male predominance in reported visceral leishmaniasis cases: nature or nurture? A comparison of population-based with health facility-reported data. PLoS Negl Trop Dis. 2020; 14(1):e0007995.
25. World Health Organization. Global leishmaniasis surveillance: 2019-2020, a baseline for the 2030 roadmap. Wkly Epidemiol Rec. 2021;96:401-20.
26. Zeinali M, Mohebali M, Shirzadi MR. Integration and evaluation of cutaneous leishmaniasis laboratory diagnosis in the primary health care laboratory network. East Mediterr Health J. 2023;29(10): 810-818.
27. World Health Organization. Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region. Cairo: WHO Regional Office for the Eastern Mediterranean; 2014. p.9.
28. Al-Khayat ZAY, Agha NFS, Alharmni KIF. Gender differences in the severity and features of lesions among cutaneous leishmaniasis patients. J Contemp Med Sci. 2019;5(6): 336–342
29. Miranda S, Roura X, Picado A, et al. Characterization of sex, age, and breed for a population of canine leishmaniosis diseased dogs. Res Vet Sci. 2008;85(1):35-8.
30. Soares L, Abad-Franch F, Ferraz G. Epidemiology of cutaneous leishmaniasis in central Amazonia: a comparison of sex-biased incidence among rural settlers and field biologists. Trop Med Int Health. 2014;19(8):988-95.
| Files | ||
| Issue | Vol 21 No 2 (2026) | |
| Section | Original Article(s) | |
| Keywords | ||
| Leishmaniasis Dogs Indirect ELISA Public health Algeria | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
